Market Place
Sourcing Support
H.I.G. Capital Completes the Sale of BIOVECTRA
23 Sep 2024 //
BUSINESSWIRE
Agilent Completes Acquisition of BIOVECTRA
21 Sep 2024 //
BUSINESSWIRE
Agilent to buy contract drug manufacturer Biovectra for $925 million
23 Jul 2024 //
REUTERS
BIOVECTRA Partners To Establish Domestic Immunotherapy Supply Chain
26 Feb 2024 //
PRESS RELEASE
CDMO Biovectra boosts Canada mRNA capabilities
27 Nov 2023 //
BIOPROCESS INTERNATIONAL
BIOVECTRA Launches Specialized Capabilities in mRNA Drug Product Development
17 Nov 2023 //
BUSINESSWIRE
BIOVECTRA Signs Service Agreement With Acuitas Therapeutics
05 Oct 2023 //
BUSINESSWIRE
BIOVECTRA Starts Construction on its Charlottetown mRNA Biomanufacturing Centre
14 Apr 2022 //
BUSINESSWIRE
BIOVECTRA mRNA Vaccine and Bio-Manufacturing Facility Announced
18 Nov 2021 //
BUSINESSWIRE
BIOVECTRA Appoints Steven M. Klosk, Gordon C. Mccauley to Board
21 Oct 2021 //
BUSINESSWIRE
Biovectra Enhances Manufacturing Capacity and Flexibility with ABEC’s Technology
20 Sep 2021 //
BIOSPACE
Mallinckrodt agrees to sell CDMO business for $250m
12 Sep 2019 //
IN-PHARMATECHNOLOGIST
Mallinckrodt Agrees to Sell BioVectra Inc. to H.I.G. Capital for $250 Million
11 Sep 2019 //
BIOSPACE
Mallinckrodt unloads its CDMO for $250M as potential liabilities mount
10 Sep 2019 //
FIERCE PHARMA
BioVectra to Invest $110M in Expansion Project
14 Mar 2019 //
CONTACT PHARMA
Keryx hires Siegfried to make Auryxia API
05 Jan 2018 //
IN PHARMATECHNOLOGIST
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.